← Browse by Condition
Medical Condition

hypertension

Total Trials
51
Recruiting Now
51
Trial Phases
Phase 4, Phase 3, Phase 2

Hypertension remains the most common treatable cardiovascular risk factor globally, yet blood pressure control rates remain suboptimal despite multiple effective drug classes. Clinical trials now investigate novel mechanisms including aldosterone synthase inhibitors, renal denervation devices, and RNA-based therapies targeting angiotensinogen to achieve durable pressure reduction with minimal pill burden.

Active research includes zilebesiran (RNA interference targeting angiotensinogen), baxdrostat (aldosterone synthase inhibitor), ultrasound renal denervation (Symplicity HTN-4), and resistant hypertension approaches combining SGLT2 inhibitors with MRA spironolactone. Ambulatory blood pressure monitoring is increasingly used as the primary endpoint instead of clinic readings.

Frequently Asked Questions — hypertension Clinical Trials

How many clinical trials are currently recruiting for hypertension?
ClinicalMetric currently tracks 51 actively recruiting clinical trials for hypertension, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 51. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hypertension?
hypertension research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (2 trials), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hypertension clinical trial?
Eligibility criteria for hypertension trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
3
Top Sponsors
Rush University Medical Center 2 trials
Istituto Auxologico Italiano 2 trials
Massachusetts General Hospital 2 trials
University of Sao Paulo 2 trials
Beth Israel Deaconess Medical Center 2 trials

Recruiting Clinical Trials

NCT03457168
Recruiting

Treatment of Hypertension During Sleep

Enrollment
5,320 pts
Location
Spain
Sponsor
University of Vigo
View Trial →
NCT06948838
Recruiting

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

Enrollment
16,895 pts
Location
United States
Sponsor
Boston Medical Center
View Trial →
NCT05220332
Recruiting

Church-based Intervention to Improve Blood Pressure in African Americans

Enrollment
312 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT07444138
Recruiting

Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women

Enrollment
20 pts
Location
Brazil
Sponsor
São Paulo State University
View Trial →
NCT06108674
Recruiting

Telepharmacy on Patients With Arterial Hypertension

Enrollment
194 pts
Location
Brazil
Sponsor
Federal University of Bahia
View Trial →
NCT05242055
Recruiting

Integrated Diagnosis and Treatment of CKD on Outcomes

Enrollment
1,000 pts
Location
China
Sponsor
Capital Medical University
View Trial →
NCT05982847
Recruiting

National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Enrollment
22,464 pts
Location
South Africa, Switze...
Sponsor
North-West University, South A...
View Trial →
NCT05106036
Recruiting

Preventing Cognitive Decline by Reducing BP Target Trial

Enrollment
4,000 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT05671406
Recruiting

RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community

Enrollment
220 pts
Location
United States
Sponsor
University of Texas at Austin
View Trial →
NCT07552571
Recruiting

Goal Commitment and Proactive Health Behavior in Chronic Disease Patients

Enrollment
600 pts
Location
China
Sponsor
Xiong Juyang
View Trial →
NCT06625346
Recruiting

Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

Enrollment
420 pts
Location
Pakistan
Sponsor
The Searle Company Limited Pak...
View Trial →
NCT06256991 Phase 4
Recruiting

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

Enrollment
44 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT05934383
Recruiting

Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension

Enrollment
40 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
View Trial →
NCT06346886
Recruiting

HTN App for HTN Control and Cardiovascular Health Among African-Americans

Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07071077
Recruiting

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

Enrollment
60 pts
Location
United States
Sponsor
University of Delaware
View Trial →
NCT06174766 Phase 3
Recruiting

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

Enrollment
324 pts
Location
South Korea
Sponsor
Hanmi Pharmaceutical Company L...
View Trial →
NCT06869031
Recruiting

Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach

Enrollment
320 pts
Location
China
Sponsor
Yuju Wu
View Trial →
NCT05293756
Recruiting

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Enrollment
208 pts
Location
United States
Sponsor
Case Western Reserve Universit...
View Trial →
NCT06309511
Recruiting

Subendocardial Viability Ratio in Hypertension

Enrollment
3,000 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →
NCT06775028
Recruiting

Integrated Approach in Frail Older People with Atrial Fibrillation

Enrollment
1,250 pts
Location
Bulgaria, Denmark, I...
Sponsor
Heart Care Foundation
View Trial →
NCT07238556
Recruiting

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Enrollment
72 pts
Location
United States
Sponsor
University of Connecticut
View Trial →
NCT06843577
Recruiting

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Enrollment
160 pts
Location
United States
Sponsor
Zona Health, Inc
View Trial →
NCT07547345
Recruiting

Mobilizing Community Hypertension Access Pilot

Enrollment
200 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT05421767 Phase 4
Recruiting

Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation

Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT07238400 Phase 2
Recruiting

Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

Enrollment
90 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07553442 Phase 2
Recruiting

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

Enrollment
93 pts
Location
United States
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT06962488
Recruiting

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

Enrollment
300 pts
Location
United States
Sponsor
University of Alabama at Birmi...
View Trial →
NCT06524180
Recruiting

Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension

Enrollment
364 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT06868069
Recruiting

Study on Blood Pressure Variability and Frailty in the Older People

Enrollment
220 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →
NCT07290842
Recruiting

The Effects of Dietary Nitrate in Patients With Hypertensive Kidney Injury

Enrollment
20 pts
Location
Denmark
Sponsor
Gødstrup Hospital
View Trial →
NCT05000996
Recruiting

Gut Microbiota in Metabolic Surgery

Enrollment
300 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT03374215
Recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Enrollment
1,150 pts
Location
United States
Sponsor
National Institute of Diabetes...
View Trial →
NCT06511479
Recruiting

Jackson Heart Study Women's Hypertension Study

Enrollment
300 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT03569735
Recruiting

Nanshan Elderly Cohort Study

Enrollment
20,000 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT06615609
Recruiting

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Enrollment
536 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT07064473 Phase 3
Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Enrollment
11,800 pts
Location
United States, Argen...
Sponsor
Boehringer Ingelheim
View Trial →
NCT02608996 Phase 1, Phase 2
Recruiting

Nesiritide in Hypertension

Enrollment
15 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT06779513
Recruiting

Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension

Enrollment
50 pts
Location
Indonesia
Sponsor
Universitas Diponegoro
View Trial →
NCT06105775
Recruiting

Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies

Enrollment
144 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT07091851
Recruiting

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

Enrollment
50 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07267871
Recruiting

Oura Blood Pressure Profile Study

Enrollment
2,000,000 pts
Location
United States
Sponsor
Ouraring Inc.
View Trial →
NCT06465134
Recruiting

Mechanisms for Atrial Fibrillation in Obstructive Sleep Apnea

Enrollment
300 pts
Location
Italy, Sweden
Sponsor
Danderyd Hospital
View Trial →
NCT06941116
Recruiting

Steroids-Based Screening for Primary Aldosteronism

Enrollment
406 pts
Location
China
Sponsor
Qifu Li
View Trial →
NCT06132451
Recruiting

In-Hospital Detection of Elevated Blood Pressure

Enrollment
800 pts
Location
Switzerland
Sponsor
Annina Vischer
View Trial →
NCT06752772
Recruiting

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Enrollment
1,700 pts
Location
Singapore
Sponsor
Alexandra Hospital
View Trial →
NCT06891911
Recruiting

Groceries for Residents of Southeastern USA to Stop Hypertension

Enrollment
150 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT06049420
Recruiting

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Enrollment
95 pts
Location
United States
Sponsor
West Virginia School of Osteop...
View Trial →
NCT06822439
Recruiting

Remote Fetal Monitoring in High Risk Pregnancies

Enrollment
50 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT07018557 Phase 4
Recruiting

Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)

Enrollment
150 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT05703386
Recruiting

Imaging the Pathogenesis of Cerebral Small Vessel Disease

Enrollment
50 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT06062394
Recruiting

Penn Medicine Healthy Heart

Enrollment
1,980 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology